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Abstract
Human erythropoietin (hEPO) is a glycoprotein that regulates the formation of 
erythrocytes and mainly used in anemia patients. Previously, we have reported the 
expression of modified human EPO with 2 additional N-linked in mammalian cell CHO-K1. 
The aim of this current research was to study the optimum condition for modified 
recombinant hEPO (rhEPO) production in CHO-K1. To do this, several parameters of 
culture conditions were applied including antibiotic concentrations, seeding densities, 
time of incubations, fetal bovine serum (FBS) concentrations and cell culture media. 
The result showed that the presence of antibiotic G418 improved the expression level 
with the highest was at 1% of concentration. Meanwhile, seeding density of 2–3x105 
cells/6 cm dish and seven day of incubation time were the best condition for rhEPO 
protein expression. From five different combination media used, F12 medium with 10% 
FBS gave the highest expression of rhEPO protein. From this study was also found that 
at passage 16 the expression level was still increasing proving that the clone expressing 
the protein of our interest is promisingly stable.  
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INTRODUCTION
 As the main protein involved in the 
maintenance of red blood cell level in the body, 
the function of erythropoietin (EPO) is highly 
regulated by the presence of oxygen in the body 
(Krantz, 1991; Lacombe, et al., 1998). The decrease 
of oxygen in tissues will enhance the production of 
EPO in kidney (D’Andrea, et al., 1989). Thus, the 
production of red blood cell is influenced by the 
level of oxygen in the body. Erythropoietin (EPO) 
is a complex and intensely glycosylayted particle 
comprising of 165 amino acids.  Its molecular mass 
is 30.4 kDa, but it relocates with an apparent size of 
34-40 kDa on SDS-polyacrylamide gels. However, 
the correct molecular weight profoundly relies upon 
the level of glycosylation. This molecule contains 
three N-linked and one O-linked carbohydrate side 
chains with maximum may contains 14 residues of 
sialic acid. Approximately, 40% of its molecular 
weight is contributed by its sugar partition (Egrie, et 
al., 1986). The N-linked sugar side chains give off an 
impression of being fundamental for the formation 
of EPO, limit clearance, increase stability, thus can 
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perform erythropoiesis normally in bone marrow 
(Fried, et al., 1972; Zanjani, et al., 1981; Yin, et 
al., 2000). Precedent study Egrie, et al. (2001) 
had demonstrated that the expansion of sialic acid 
content of EPO with the integration of 2-N linked 
can increase serum half-life and biological activity. 
Insufficiency of EPO becomes one of the main 
causes of cancer anemia, this makes the use of 
recombinant therapeutic protein EPO becomes 
one of the solutions (Kasper, et al., 1997). Present 
study shows that EPO is very beneficial to alleviate 
cancer-associated malignant anemia and can 
improve survival outcomes for patients with cancer 
(Zhao, et al., 2017).  Mortality among patients with 
anemia is twice as high as that among those without 
anemia at three year post-cancer diagnosis (Rice, et 
al., 1999; Leng, et al., 1999., Chung, et al., 2003). 
This indicates that the use of EPO in treating cancer 
anemia can be very helpful. 
 With numerous licenses for the principal 
biologicals derived from recombinant innovation 
are terminating. Normally, biosimilars are becoming 
an increasingly consequential area of interest for the 
pharmaceutical industry globally and this likewise 
opens up open doors for creating nations to deliver 
their own particular biologic items (Katherine, 
et al., 2014; Blakstone, et al., 2013; Declerck, et 
al., 2017). With the long haul objective of creating 
biosimilar EPO, investigation of human EPO 
molecule containing 2 extra N-linked in mammalian 
cell CHO-K1 is in progress. We already reported 
the expression of this modified recombinant human 
EPO (rhEPO) in CHO-K1 cells and its in vitro 
proliferative activity in TF-1 cells (Santoso, et al., 
2014). 
 The objective of this current study is to 
obtain the optimum conditions of expression 
of hEPO protein in mammalian cells CHO-K1 
using general commercial media. The optimation 
of culture conditions under study includes 
antibiotic concentrations, seeding densities, 
time of incubations, fetal bovine serum (FBS) 
concentrations and cell culture media.
MATERIALS AND METHODS
Cell culture and reagents
 The CHO-K1 cells were obtained from Prof. 
Masashi Kawaichi, Nara Institute of Science and 
Technology  (NAIST),  Japan.  The  cells  were 
cultured in Nutrient Mixture F-12 Ham (F12) 
media  (Sigma  N6658)  in  the  presence of 10% 
of fetal bovine serum (FBS, Sigma), 100U of 
benzylpenicillin  and 100 μg of streptomycin 
(Gibco, Invitrogen). CHO-K1 cells were transfected 
with plasmid J-EPO, (pJ-EPO) containing 2 
additional N links and the stable cells expressing 
rhEPO were used for this study (Santoso, et al., 
2014). As much as 1% of antibiotic G418 (Sigma, 
A1720) was added to the media just before use to 
maintain protein expression. The cell was cultured 
in  an  incubator  with  the  condition  of  5%  CO2 
and  37oC  temperature.  Unless  otherwise  stated, 
the number of cell seeded was 1.5x105 cells/6 cm 
dish. The cells were seeded in 5 mL media in 6 cm 
dish.
Optimation study
 For the optimation study, the procedure 
is described as follow: 1) antibiotic G418 
concentrations: the cells were cultured with the 
addition of 0, 0.5, 1, 1.5 and 2% of antibiotic 
G418 in F12  medium plus 10% FBS, 2) seeding 
density:  the  cells  were  cultured  for  four  days 
in  F12 medium in  the  presence  of  10%  FBS, 
1%  antibiotic G418, and seeded as many as 
2x105, 3x105, 4x105 and 5x105 cells/6 cm dish; 3) 
incubation  time:  the  cells  were  cultured  in  F12 
medium  in  the  presence  of  10%  FBS  with 
seeded  cells  as  many as 2x105 cells/6 cm dish and 
incubated for 2, 3, 4, 5, 6 or 7 days in the presence 
of 1% antibiotic G418, respectively;  and  4)  media 
and  its  concentrations: the cells were cultured 
in CD-CHO (100%), CD-CHO/F12  (3:1)/2.5% 
FBS,  SFM  (100%),  SFM/F12 (3:1)/2.5% FBS 
and F12/10% FBS media in the presence of 1% 
antibiotic G418.  
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SDS-PAGE and Western blotting. 
 The purity of the protein analyzed by SDS/
PAGE performed as previously described in a 12% 
separating gel with a 5% stacking gel using the 
Mini-PROTEAN-3 apparatus (BioRad, Hercules, 
CA, USA). Following electroporation, proteins 
were transferred to Amersham Hybond ECL (GE 
Healthcare) by electroblotting. Western blots 
were performed using polyclonal anti human EPO 
antibody (Sigma, St. Louis, MO, USA) as the primary 
antibody and anti-rabbit IgG alkaline phosphatase 
linked whole antibody (Promega, Madison, WI, 
USA) as the secondary antibody. The bands were 
detected by BCIP/NBT color development substrate 
(5-bromo-4-chloro-3-indolyl-phosphate/nitro blue 
tetrazolium) (Promega, Madison WI, USA).
RESULTS
 Several techniques of transfection strategies 
have been established to steadily integrate 
vector DNA into mammalian cells. Previously, 
we also reported the optimization cationic lipid 
mediated transfection of pJ-EPO in CHO-K1 
cells (Septisetyani, et al., 2012). The transfected 
cells were selected in view of aminoglycoside 
phosphotransferase (antibiotic G418) selectable. 
To evaluate the antibiotic G418 concentration in 
relation to rhEPO expression and cell growth, 
several concentrations of antibiotic G418 were 
added to the F12 growth media in the presence of 
10% FBS.  
 Data shows (Figure 1A) that the rhEPO protein 
bands present around 34-45 kDa corresponded to 
the theoretical molecular mass for the EPO that 
the exact molecular weight highly depends on the 
degree of glycosylation.  As shown in Figure 1A 
the rhEPO protein expression was approximately 
the same at 0, 0.5 and 1.5% of G418 antibiotic 
concentration; and the highest is at 1%.  However, 
at highest G418 antibiotic concentration (2%), 
the expression dropped. To examine the presence 
of antibiotic G418 on the growth of the cells, cell 
densities were observed after 4 days of incubation. 
The data reveals that at 0-0.5% of antibiotic 
G418, the cell densities are, approximately, the 
same (7x105 cells/6 cm dish). However, at higher 
concentration (1-2% of antibiotics), the cell density 
dropped, approximately, to 5 to 6x105 cells/6 cm 
dish, respectively.
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Figure 1. Expression of rhEPO protein in CHO-K1 cell 
in several antibiotic G418 concentrations. The 
cells (200,000 cells/6 cm dish) were cultured for 
4 days. A: Western blot analysis of CHO-K1 cells 
expressing rhEPO. Lane 1-5 correspond to 2, 
1.5, 1, 0.5 and 0% of antibiotic concentrations, 
respectively. B: Cell densities after four days of 
incubation.
 To analyze the stability of the cells to express 
rhEPO protein, the cells were passaged for 5 times 
in the presence (1%) or absence of antibiotic 
G418. The results show that both cells were able to 
express rhEPO; and the expression level increased 
with more passage numbers (Figure 2A and B). The 
data showed that at passage 16, the expression level 
(in the presence of 1% antibiotic G418) was still 
increasing (Figure 2C).
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Figure 2. Western blot analysis of CHO-K1 cells ex-
pressing rhEPO protein with or without antibi-
otic G418 in F12 medium in the presence of 10% 
FBS. A: The cells were cultured without anti-
biotic G418. Lane 1-5 corresponds to 1-5 pas-
sage numbers, respectively. B: The cells were 
cultured in the presence of 1% antibiotic G418. 
Lane 1-5 corresponds to 1-5 passage numbers, 
respectively. C: The cells were cultured in the 
presence of 1% antibiotic G418. Lane 1-4 cor-
responds to cells with passage numbers 13-16, 
respectively.
To further optimize the best condition for the cell 
to grow, next step for this optimation study is to evaluate 
the number of cell seeded. To do this, several numbers of 
cells were seeded in F12 + FBS 10% medium. Following 
four days of incubation, the numbers of cells were 
counted and the protein hEPO expression was analyzed 
using Western blot. The data in Figure 3A reveals that 
higher expressions were observed at seeding density of 
2x105 and 3x105 cells/6 cm dish. While lower expressions 
were observed at higher seeding density (4x105 and 
5x105 cells/6 cm dish). After 4 days of incubation, the 
cell densities linearly correlated with the number of 
cell seeded with the lowest and highest were when the 
cells were seeded at 2x105 and 5x105 cells/6 cm dish, 
respectively (Figure 3B).
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Figure 3. Optimation of CHO-K1 cell seeding density. 
A: Western blot analysis of CHO-K1 cells express-
ing rhEPO. Lane 1-4 correspond to cell densities 
of 200,000; 300,000; 400,000 and 500,000 
cells/6 cm dish. B: Cell densities after four days 
of incubation.
To further evaluate for how long the cell has to be 
cultured to obtain the highest titer, 200,000 cells/6 cm 
media was cultured in F12 + FBS 10% medium. The 
cells were cultured and harvested everyday from day 
two to seven.  As revealed in Figure 4A, optimation of 
incubation time indicates a linear relationship between 
time of incubation and level of expression. The data 
shows that seven days of incubation time gave the 
highest level of expression. While, the lowest level of 
expression occurred at two days of incubation. The cell 
density data showed that cell number increases with the 
increase of incubation time; and the peak occurred at day 
four with the total number of cell was, approximately, 
6x105 cells/6 cm dish. After four days of incubation, 
the cell density decreases sharply until at seven days 
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Figure 4. Optimation of incubation time. Cells were 
seeded at density 200,000 cells/6 cm dish and 
incubated for 2, 3, 4, 5, 6 or 7 days (1-6 re-
spectively). A: hEPO protein expression. B: Cell 
density at harvesting day.
of incubation. This result indicated that higher protein 
expression was obtained at longer incubation time 
without showing correlation with the cell density.
 With the advance of biologic medicines, 
manufacturing of protein therapeutic products with 
the use of CHO cells has become the preferred choice. 
However, one of the main problems in this system 
is that most of mammalian cells have to grow in the 
presence of FBS. The presence of FBS may complicate 
the downstream process of the biologics of interest 
(Reinhart, et al., 2013). Thus, one of the goals of this 
study is to evaluate how the cells grow in several media 
including serum free media. To do this, the cells were 
grown in several media and followed by observation 
of its expression and cell density (Figure 5). From the 
five different media used, SFM/F-12(3:1)/2.5% FBS and 
F12/10% FBS media gave, approximately, the same level 
of rhEPO protein expressions (Figure 5A), followed 
by CD-CHO/F12 (3:1)/2.5% FBS and SFM 100%. To 
have a better understanding of the protein expression 
in relation to the cell growth, the cells grown in several 
media were counted. The data shows that the highest 
cell density was found when the cells grown in SFM/
F12 (3:1)/FBS 2.5% medium followed by CD-CHO/F12 
(3:1)/FBS 2.5%, F12/10% FBS, CD-CHO (100%), and 
SFM (100%), respectively.
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Figure 5. Expression of rhEPO protein in CHO-K1 cell 
line in several media. A: Western blot analysis of 
CHO-K1 cell conditioned media. Lane 1-5 corre-
spond to CD-CHO 100%, CD-CHO:F12 (3:1)/FBS 
2.5%, SFM 100%, SFM:F12/FBS (3:1)/FBS 2.5% 
and F12/10%FBS in the presence of 1% antibiotic 
G418, respectively. B: Cell density after four day 
incubation.
DISCUSSION
 These days, cell culture has transformed into 
one of chief fields in present day biotechnology, 
especially in the field of human wellbeing. 
Advancement of development in interdisiplinary 
fields, for example, human medication, cell science 
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and biotechnology has provoked the generation 
of biologics including vaccines, hormones and 
monoclonal antibodies (Feng, et al., 2010; Kunert, 
et al., 2016). Nonetheless, since a large portion of 
these particles are glycoproteins, post-translational 
adjustment stages are exceptionally indispensable 
(Matasci, et al., 2008). To oblige this condition the 
utilization of mammalian cell culture innovation is 
vital. With the use of limiting dilution technique, 
our previous work (Septisetyani, et al., 2012) was 
able to clone CHO-K1 cell transformant harboring 
codon optimized human epo gene containing five 
N-linked oligosaccharide chains. To optimize the 
growth and titer of the obtained clone, the cloned 
cell was observed in several conditions including 
antibiotic concentrations, type of media, times of 
incubation and numbers of cell seeded.
 One of antibiotic frequently used in 
mammalian cell line work is antibiotic G418 
(Feng, et al., 2010). To observe how the titer and 
growth of our cell transformant performed in the 
presence of antibiotic G418 concentration, several 
concentrations of this antibiotic were applied 
in CHO-K1 cell transformant harboring codon 
optimized human epo gene. The result showed that 
the highest expression of rhEPO protein occurred at 
1% antibiotic concentration. Interesting to note that 
at 0% of antibiotic concentration, as seen in Figure 
1A, the concentration of rhEPO was relatively high. 
It is known that when transfected cells were kept 
under selective pressure (for example antibiotic 
G418 or methotrexate), the expression level of the 
gene of interest stably maintained at high level and 
the reverse occurred in the absence of selective 
pressure. Thus, the higher protein expression at 
zero concentration of antibiotic G418 than that of 
2% has to be taken caustiously at higher passage 
numbers. It is possible that with the increasing 
number of passage, in the absence of selective 
pressure, the expression of the protein will decline. 
In another word, the presence of selective pressure 
may be needed to keep the expression of protein of 
interest to remain high. In case of cell density, the 
data shows that the cell number drops at 1–2% of 
antibiotic G418 concentration. The decrease of the 
cell density, especially at the highest concentration 
(2%), was followed by the decrease of the protein 
expression (Figure 1).
 Consistent gene expression for specific period 
of time is the main indication of stable cell lines. 
Unfortunately, obtaining stable cell lines can be 
exceptionally costly and tedious (Feng, et al., 
2010; Bussow, et al., 2015). To analyze the stability 
of our cloned cells, the cells were cultured in the 
presence and absence of 1% of antibiotic G418 for 
16 passages. The number of passage starts when 
the cells were treated with experimental treatment. 
As seen in Figure 2, the cells were still strongly 
expressing the protein of our interest meaning that 
the cells were stable. Interesting to note that at 
16 passages, the trend of the expression was still 
increasing indicating that there is a high possibility 
that our gene of interest was inserted stably into the 
genome of the cell.
 Seeding density in cell culture may play 
crucial role in subsequent cell division, particularly 
if that has to do with specific cell line (Zhou, et 
al., 2011). Following seeding, cell development in 
culture begins from the slack stage to the log stage 
where the development turns to grow exponentially 
(Rolfe, et al., 2012).  In adherent system, normally, 
cells quickly grow until no room left for expansion. 
At this point, proliferation greatly reduced and 
finally, ceases completely. To ensure the cell culture 
keeps on developing, the cell culture has to be 
passaged at the right time.
 Considering the dynamic growth of cell 
explained above, optimum seeding density become 
important. To observe the optimum number of cell 
seeded, several cell densities (2, 3, 4 and 5x105 
cells/6 cm dish) were seeded. The result showed 
that the highest expression was obtained when the 
cell was seeded at 2–3x105 cells/6 cm dish (Figure 
3). It is natural to expect that the highest seeding 
density would give the highest expression level.   
 However, the data obtained showed that 
the highest seeding density (4x105 cells/6 cm dish) 
did not give the highest expression level. The likely 
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explanation of this data was that lower seeding 
density (2–3x105 cells/6 cm dish) gave the optimum 
condition for the cells to synthesize the rhEPO 
protein. The inverse relationship between the 
protein expression and cell growth may reflect the 
balance nutrients requirement of cells at particular 
time.
 To some extent time of incubation of cell 
culture is related to the amount of protein being 
expressed. To observe for how long the cell has to 
be cultured in order to obtain the highest expression 
level, the cells were cultured for seven days. A 
linear relationship pattern was obtained between 
degree of expression level and time of incubation 
with the highest at day seven. Having known the 
relation between expression and time of incubation, 
the relationship between time of incubation and 
cell density was then observed. The data showed 
that cell density increases with the increase of 
incubation time. After reaching the peak at day four 
the cell density decreases sharply with the lowest 
at seven days of incubation (Figure 4). Thus, the 
peak of cell density was not followed by the peak 
of protein expression. This data might show that it 
takes time for the cell to synthesize the protein of 
interest (rhEPO) that finally peaked at day seven.
 In term of scalability, mammalian cells have 
historically been considered to be difficult to work 
due to factors such as low yield, serum requirement 
and medium complexity (Reinhart, et al., 2013; 
Carrillo, et al., 2015). The data (Figure 5) shows 
that the presence of FBS is significant for the 
growth and expression of the protein of interest 
with the highest was at 10% of FBS. Interesting to 
note that the expression level at FBS 10% (in F12) 
and 2.5% [in SFM/F12 (3:1)] are, aproximately, 
the same. However, the protein expression in 2.5% 
FBS [in CD-CHO/F12 (3:1)] was little lower. The 
low protein expression in SFM (100%) and almost 
no expression at all in CD-CHO (100%) were 
understandable since the attachment of CHO-K1 
cell required FBS (Figure 5). While FBS can 
bolster the development of numerous types of cells, 
however, the type of its particular components 
that are critical for every individual cell have not 
yet been recognized thoroughly (Shahdadfar, et 
al., 2005; Valk, et al., 2017). Mostly in the form 
of FBS, serum has been utilized in cell culture for 
a considerable length of time, and its utilization is 
really expanding. Serum may not be the suitable 
enhancement to use in cell culture, particularly if 
the protein was planned for biopharmaceutical items 
for use in human (Schroder, et al., 2004; Zhang, et 
al., 2013). The use of serum free media has picked 
up acknowledgment and significance, nonetheless, 
building up a powerful serum free media has been 
troublesome (Freshney, 2010; Valk, et al., 2017), 
as demonstrated in this work that the utilization of 
10% FBS gave the best results.
 Expansion and competition of costly biologics 
have fuelled endeavors to enhance and upgrade 
cell culture media with the aim of achieving 
greatest outcomes and bringing down the expense 
of production (Valk, et al., 2017; Tatsuma and 
Asayama, 2017). Commonly now, due to the need 
to support high cell densities and efficiency, the 
media used for biologics production are without 
serum and have substantially higher supplement 
fixations than traditional media (Carrillo, et al., 
2015). Cell growth and viability are paramount 
for biologics production. However, when serum is 
basically needed for some cells to grow, the growth 
and achieving the cells to express the protein of 
interest becomes very challenging (Fontes, et 
al., 2014). As productivity and growth can have 
inverse relationship, and the cell limited resources 
are divided between those two functions, nutrient 
essential for growth may compete with those for 
protein production. To face this problem, initial 
and thorough optimation is extremely important for 
having the highest protein production possible in 
mammalian cell culture.
CONCLUSION
 This research has shown that to certain 
extent antibiotic G418 improves the hEPO 
protein expression level with the highest was at 
14
Santoso, et al, 2019
Indones. J. Cancer Chemoprevent., 10(1), 7-15
1% of concentration. Seeding density and time of 
incubation affect the expression level with the best 
conditions are at 2–3x105 cells/6 cm dish and seven 
day of incubation time, respectively. Medium F12 
with 10% FBS proves to be the best medium for 
rhEPO expression. However, the use of SFM/F12 
(3:1) medium with lower concentration of FBS 
(2.5%) also gave promising result. Observed for 16 
passages, the expression level was still increasing 
indicating that the clone is stable.
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